ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 208

$1.42M Total Retail Price of All Prescriptions

Rank: 3 out of 208

849 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 849 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

5% of this provider’s 849 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 16,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
METOPROLOL TARTRATE 947 795 1 2
FUROSEMIDE 694 603 2 6
SIMVASTATIN 639 577 3 9
AMLODIPINE BESYLATE 600 565 4 5
POTASSIUM CHLORIDE 526 470 5 19
LISINOPRIL 519 433 6 1
ATORVASTATIN CALCIUM 506 417 7 11
METOPROLOL SUCCINATE 488 436 8 4
CLOPIDOGREL 462 370 9 8
LEVOTHYROXINE SODIUM 456 408 10 31
WARFARIN SODIUM 449 403 11 7
PRAVASTATIN SODIUM 412 351 12 13
OMEPRAZOLE 370 293 13 28
CARVEDILOL 314 255 14 3
PLAVIX 313 268 15 12
CRESTOR 269 233 16 15
NEXIUM 261 218 17 47
LOSARTAN POTASSIUM 259 243 18 17
GLIMEPIRIDE 257 197 19 78
METFORMIN HCL 245 204 20 49
CITALOPRAM HBR 217 177 21 67
DIGOXIN 197 155 22 14
HYDROCODONE-ACETAMINOPHEN 194 147 S3 23 32
KLOR-CON M20 194 158 23 33
HYDROCHLOROTHIAZIDE 190 160 25 18
PRADAXA 171 129 26 27
ATENOLOL 171 139 26 16
DIOVAN 167 160 28 30
ISOSORBIDE MONONITRATE ER 162 139 29 10
TRAMADOL HCL 162 143 29 77
SOTALOL 158 131 31 24
MULTAQ 156 131 32 46
JANUVIA 151 137 33 96
VERAPAMIL ER 144 122 34 86
AMLODIPINE BESYLATE-BENAZEPRIL 142 112 35 68
METFORMIN HCL ER 140 119 36 112
DILTIAZEM 24HR ER 136 117 37 38
SINGULAIR 136 111 37 84
FAMOTIDINE 134 106 39 87
GABAPENTIN 132 100 40 58
RAMIPRIL 129 109 41 25
RANITIDINE HCL 128 100 42 50
SPIRONOLACTONE 126 105 43 21
DILTIAZEM 24HR CD 119 96 44 40
CLONIDINE HCL 117 106 45 39
ALLOPURINOL 112 100 46 76
MELOXICAM 111 98 47 94
BENAZEPRIL HCL 105 86 48 82
TRIAMTERENE-HCTZ 100 92 49 72
TRICOR 100 80 49 59
TRAZODONE HCL 100 100 49 102
ZETIA 99 75 52 34
KLOR-CON 10 95 60 53 131
HYDRALAZINE HCL 93 76 54 35
LIPITOR 90 84 55 48
TOPROL XL 88 86 56 117
NITROSTAT 86 76 57 23
SERTRALINE HCL 86 66 57 88
PANTOPRAZOLE SODIUM 85 82 59 42
FENOFIBRATE 84 61 60 53
DILTIAZEM HCL 73 62 61 91
DILTIAZEM ER 72 72 62 57
NIFEDIPINE ER 71 70 63 61
AMIODARONE HCL 71 65 63 20
PROAIR HFA 71 63 63 98
LANSOPRAZOLE 69 69 66 105
TORSEMIDE 68 60 67 52
DONEPEZIL HCL 68 68 67 93
MONTELUKAST SODIUM 68 57 67 108
SYNTHROID 67 63 70 191
ISOSORBIDE DINITRATE 65 53 71 75
AZITHROMYCIN 65 56 71 100
PROPAFENONE HCL 62 58 73 60
ZOLPIDEM TARTRATE 62 60 73 81
ALENDRONATE SODIUM 60 55 75 120
CEPHALEXIN 60 48 75 116
INSULIN SYRINGE 59 47 77 128
ESCITALOPRAM OXALATE 58 52 78 159
LOSARTAN-HYDROCHLOROTHIAZIDE 58 51 78 43
ONGLYZA 57 54 80 158
MIDODRINE HCL 56 48 81 163
BYSTOLIC 54 50 82 29
RANEXA 53 46 83 22
NIASPAN 52 45 84 41
GEMFIBROZIL 51 51 85 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.